Sectors

QTTB
Q32 Bio Inc.
14.87
1 x 14.79
1 x 14.90
bid
ask
-
0.16
1.06%
1 @ 04:00 PM
15.62 +0.75 (5.06%)
Ytd347.89%
1y769.59%
14.75
day range
15.32
1.62
52 week range
23.57
Open14.86Prev Close15.03Low14.75High15.32Mkt Cap442.67M
Vol348.35KAvg Vol1.16MEPS3.14P/E4.74Forward P/E-0.60
Beta0.23Short Ratio6.74Inst. Own86.21%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0650-d Avg14.88200-d Avg7.761yr Est17.40
Income Statement
Operating Expenses9.12M
Research and Development Expense4.26M
Selling, General and Administrative Expense4.86M
Operating Income-9.12M
Net Income-8.95M
Net Income Common Stock-8.95M
Net Income Common Stock (USD)-8.95M
Consolidated Income-8.95M
Earnings per Basic Share-0.44
Earnings per Basic Share (USD)-0.44
Earnings per Diluted Share-0.44
Earning Before Interest & Taxes (EBIT)-8.95M
Earning Before Interest & Taxes (USD)-8.95M
Weighted Average Shares20.34M
Weighted Average Shares Diluted20.34M
Balance Sheet
Cash and Equivalents106.92M
Cash and Equivalents (USD)106.92M
Current Assets109.65M
Property, Plant & Equipment Net5.57M
Total Assets115.87M
Total Debt4.56M
Current Liabilities5.40M
Debt Non-Current4.56M
Total Liabilities9.96M
Accumulated Retained Earnings (Deficit)-221.55M
Shareholders Equity105.91M
Shareholders Equity (USD)105.91M
Assets Non-Current6.22M
Total Debt (USD)4.56M
Liabilities Non-Current4.56M
Trade and Non-Trade Payables1.57M
Cash Flow
Depreciation, Amortization & Accretion252.00K
Net Cash Flow from Financing58.59M
Net Cash Flow / Change in Cash & Cash Equivalents55.52M
Issuance (Purchase) of Equity Shares66.85M
Issuance (Repayment) of Debt Securities -8.26M
Net Cash Flow from Operations-3.07M
Share Based Compensation1.69M